Xing L - Search Results

1

A new strategy for hydrophobic drug delivery using a hydrophilic polymer equipped with stacking units.

Cui PF , Zhuang WR , Hu X , Xing L , Yu RY , Qiao JB , He YJ , Li F , Ling D , Jiang HL . Cui PF , et al. Among authors: xing l. Chem Commun (Camb). 2018 Jul 19;54(59):8218-8221. doi: 10.1039/c8cc04363a. Chem Commun (Camb). 2018. PMID: 29985496

2

Synthesis of core-shell coordination polymer nanoparticles (CPNs) for pH-responsive controlled drug release.

Xing L, Cao Y, Che S. Xing L, et al. Chem Commun (Camb). 2012 Jun 18;48(48):5995-7. doi: 10.1039/c2cc30877k. Epub 2012 May 10. Chem Commun (Camb). 2012. PMID: 22576702

3

Aerosol delivery of programmed cell death protein 4 using polysorbitol-based gene delivery system for lung cancer therapy.

Kim YK, Xing L, Chen BA, Xu F, Jiang HL, Zhang C. Kim YK, et al. Among authors: xing l. J Drug Target. 2014 Nov;22(9):829-38. doi: 10.3109/1061186X.2014.932796. Epub 2014 Jul 1. J Drug Target. 2014. PMID: 24983766

4

A novel potential biocompatible hyperbranched polyspermine for efficient lung cancer gene therapy.

Xie RL, Jang YJ, Xing L, Zhang BF, Wang FZ, Cui PF, Cho MH, Jiang HL. Xie RL, et al. Among authors: xing l. Int J Pharm. 2015 Jan 15;478(1):19-30. doi: 10.1016/j.ijpharm.2014.11.014. Epub 2014 Nov 11. Int J Pharm. 2015. PMID: 25448566

5

Mitochondria apoptosis pathway synergistically activated by hierarchical targeted nanoparticles co-delivering siRNA and lonidamine.

Zhang BF, Xing L, Cui PF, Wang FZ, Xie RL, Zhang JL, Zhang M, He YJ, Lyu JY, Qiao JB, Chen BA, Jiang HL. Zhang BF, et al. Among authors: xing l. Biomaterials. 2015 Aug;61:178-89. doi: 10.1016/j.biomaterials.2015.05.027. Epub 2015 May 16. Biomaterials. 2015. PMID: 26004233

6

PK11195-chitosan-graft-polyethylenimine-modified SPION as a mitochondria-targeting gene carrier.

Kim YK, Zhang M, Lu JJ, Xu F, Chen BA, Xing L, Jiang HL. Kim YK, et al. Among authors: xing l. J Drug Target. 2016;24(5):457-67. doi: 10.3109/1061186X.2015.1087527. Epub 2015 Sep 22. J Drug Target. 2016. PMID: 26390926

7

Biocompatible polymeric nanocomplexes as an intracellular stimuli-sensitive prodrug for type-2 diabetes combination therapy.

Wang FZ, Xie ZS, Xing L, Zhang BF, Zhang JL, Cui PF, Qiao JB, Shi K, Cho CS, Cho MH, Xu X, Li P, Jiang HL. Wang FZ, et al. Among authors: xing l. Biomaterials. 2015 Dec;73:149-59. doi: 10.1016/j.biomaterials.2015.09.013. Epub 2015 Sep 11. Biomaterials. 2015. PMID: 26409000

8

Codelivery of Doxorubicin and shAkt1 by Poly(ethylenimine)-Glycyrrhetinic Acid Nanoparticles To Induce Autophagy-Mediated Liver Cancer Combination Therapy.

Wang FZ, Xing L, Tang ZH, Lu JJ, Cui PF, Qiao JB, Jiang L, Jiang HL, Zong L. Wang FZ, et al. Among authors: xing l. Mol Pharm. 2016 Apr 4;13(4):1298-307. doi: 10.1021/acs.molpharmaceut.5b00879. Epub 2016 Mar 16. Mol Pharm. 2016. PMID: 26894988

9

Polyamine metabolism-based dual functional gene delivery system to synergistically inhibit the proliferation of cancer.

Cui PF, Xing L, Qiao JB, Zhang JL, He YJ, Zhang M, Lyu JY, Luo CQ, Jin L, Jiang HL. Cui PF, et al. Among authors: xing l. Int J Pharm. 2016 Jun 15;506(1-2):79-86. doi: 10.1016/j.ijpharm.2016.04.039. Epub 2016 Apr 19. Int J Pharm. 2016. PMID: 27102990

10

In vivo synergistic antitumor effect and safety of siRNA and lonidamine dual-loaded hierarchical targeted nanoparticles.

Zhang BF, Xing L, Qiao JB, Cui PF, Wang FZ, Zhang JL, Xu CX, Jiang HL. Zhang BF, et al. Among authors: xing l. Int J Pharm. 2016 Jun 15;506(1-2):207-13. doi: 10.1016/j.ijpharm.2016.04.056. Epub 2016 Apr 22. Int J Pharm. 2016. PMID: 27113867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,930 results

Search Page

Filters